KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Goodwill (2016 - 2025)

Historic Goodwill for Neogenomics (NEO) over the last 12 years, with Q3 2025 value amounting to $524.3 million.

  • Neogenomics' Goodwill rose 30.19% to $524.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $524.3 million, marking a year-over-year increase of 30.19%. This contributed to the annual value of $522.8 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Neogenomics' Goodwill stood at $524.3 million, which was up 30.19% from $524.1 million recorded in Q2 2025.
  • Neogenomics' Goodwill's 5-year high stood at $527.1 million during Q4 2021, with a 5-year trough of $211.1 million in Q1 2021.
  • Over the past 5 years, Neogenomics' median Goodwill value was $522.8 million (recorded in 2022), while the average stood at $506.2 million.
  • In the last 5 years, Neogenomics' Goodwill skyrocketed by 14971.93% in 2021 and then plummeted by 82.51% in 2022.
  • Neogenomics' Goodwill (Quarter) stood at $527.1 million in 2021, then dropped by 0.83% to $522.8 million in 2022, then changed by 0.0% to $522.8 million in 2023, then changed by 0.0% to $522.8 million in 2024, then increased by 0.3% to $524.3 million in 2025.
  • Its Goodwill was $524.3 million in Q3 2025, compared to $524.1 million in Q2 2025 and $522.8 million in Q1 2025.